✦ LIBER ✦

Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets

✍ Scribed by Jiang, Mali; Wang, Jiawei; Fu, Jinrong; Du, Lin; Jeong, Hyunkyung; West, Tim; Xiang, Lan; Peng, Qi; Hou, Zhipeng; Cai, Huan; Seredenina, Tamara; Arbez, Nicolas; Zhu, Shanshan; Sommers, Katherine; Qian, Jennifer; Zhang, Jiangyang; Mori, Susumu; Yang, X William; Tamashiro, Kellie L K; Aja, Susan; Moran, Timothy H; Luthi-Carter, Ruth; Martin, Bronwen; Maudsley, Stuart; Mattson, Mark P; Cichewicz, Robert H; Ross, Christopher A; Holtzman, David M; Krainc, Dimitri; Duan, Wenzhen

Book ID: 119998034
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 997 KB
Volume: 18
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm.2558

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resveratrol-Activated AMPK/SIRT1/Autopha

Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease

✍ Wu, Yuncheng; Li, Xinqun; Zhu, Julie Xiaohong; Xie, Wenjie; Le, Weidong; Fan, Zh 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 650 KB

Activation of Elk-1 participates as a ne

Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington’s disease

✍ Marta Anglada-Huguet; Albert Giralt; Esther Perez-Navarro; Jordi Alberch; Xavier 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

Neuroprotective potential of CB1 recepto

Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease

✍ EL Scotter; CE Goodfellow; ES Graham; M Dragunow; M Glass 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 962 KB

Reduced calcineurin protein levels and a

Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity

✍ Xavier Xifró; Albert Giralt; Ana Saavedra; Juan M. García-Martínez; Miguel Díaz- 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 980 KB

A potent and selective Sirtuin 1 inhibit

A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease

✍ Smith, M. R.; Syed, A.; Lukacsovich, T.; Purcell, J.; Barbaro, B. A.; Worthge, S 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 657 KB

Impaired Long-Term Potentiation in the P

Impaired Long-Term Potentiation in the Prefrontal Cortex of Huntington’s Disease Mouse Models: Rescue by D1 Dopamine Receptor Activation

✍ Dallérac, G.M.; Vatsavayai, S.C.; Cummings, D.M.; Milnerwood, A.J.; Peddie, C.J. 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 756 KB